Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Weight Loss 1Pancreatic Neoplasms 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Body Weight 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Mirtazapine × Clear all
NCT04155008 2022-11-16

Nutrition and Pharmacological Algorithm for Oncology Patients Study

Montefiore Medical Center

Phase 4 Terminated
1 enrolled 5 charts
GastrointestinalHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Malnutrition

NCT00832520 2018-04-10

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

New Mexico Cancer Research Alliance

Phase 2 Terminated
13 enrolled 4 charts

Body Weight, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡